Korean J Ophthalmol > Volume 33(2); 2019 > Article
Choe, Lee, Khwarg, and Kim: Rare Case of Nerve Sheath Myxoma of the Eyelid Misdiagnosed as Mucocele
Dear Editor,
Nerve sheath myxoma was first described by Harkin and Reed [1] as a rare, myxoid, and loosely cellular benign tumor of peripheral nerve origin. Nerve sheath myxoma usually develops in the extremities, but can rarely be found in the eyelid. Only 10 cases of eyelid nerve sheath myxoma and its similar entities, including neurothekeoma, have been previously reported to our knowledge, but none of these cases were reported in Korea [2,3]. Thus, here we report the first case of nerve sheath myxoma of the eyelid in Korea.
A 34-year-old male visited our hospital with a recurrent, painless, round and non-movable soft subcutaneous mass on the right upper eyelid near the medial canthus (Fig. 1A). He had undergone two previous excisional procedures, with this being the third recurrence at the same site.
The right medial canthal mass in question first appeared 15 years ago. The initially round, about 5-mm-sized, painless, non-erythematous mass had increased in size over time. He had visited another tertiary center 14 years ago and underwent excision and biopsy. The pathologic diagnosis was “mucocele.” Six years later, an eyelid mass with similar characteristics recurred at the same site and the patient visited another hospital. The orbit computed tomography showed focal, nonspecific increased soft tissue opacity in the medial preseptal area of the right orbit. Two masses sized 1 cm × 0.5 cm × 0.5 cm at the muscle layer were excised; however, the details of the surgical procedure and whether the mass was completely excised or not were not described. The histopathologic diagnosis here was also “mucocele.”
Six months after the excision, a mass reappeared. The patient came to our institute seven and a half years later, during which the mass remained stationary in size. The preoperative orbit computed tomography showed a 1-cm-sized, ill-defined enhancing soft tissue lesion at the right medial canthal area. There were no definite cystic lesions indicating mucocele (Fig. 1B). We excised the right medial canthal mass completely, by dissecting a few lobulated masses from the medial canthal tendon (Fig. 1C). The histopathologic examination revealed that stellate and spindle cells were within a bluish myxoid matrix by fibrous bands. The cells presented a strong positive signal for S-100 immunohistochemical staining, consistent with nerve sheath myxoma (Fig. 1D, 1E).
Nerve sheath myxoma is a myxoid peripheral nerve sheath tumor with a propensity for onset in the extremities and a high local recurrence rate, particularly among patients in their third and fourth decades of life [4]. Nerve sheath myxoma is often misdiagnosed as one of other benign slow-growing eyelid lesions including neurofibroma, chalazion [2], or mucocele as a result of its painless and soft features. Since there are no distinctive clinical symptoms of nerve sheath myxoma, pathological findings are essential in properly diagnosing this condition. Also, it is important that nerve sheath myxoma be distinguished from neurothekeoma. Traditionally, nerve sheath myxoma has been regarded as a myxoid subgroup of neurothekeoma. However, recent studies have shown that nerve sheath myxoma and neurothekeoma are two separate disease entities [5]. Immunohistochemical staining of S-100 is most important for the differential diagnosis of nerve sheath myxoma and neurothekeoma, in that it shows positivity for nerve sheath myxoma and negativity for neurothekeoma [5]. Because nerve sheath myxoma is likely to recur at the same site, complete surgical excision with clear margins is the treatment of choice.


Conflict of Interest: No potential conflict of interest relevant to this article was reported.


1. Harkin JC, Reed RJ. Tumors of the peripheral nervous system. Washington, DC: Armed Forces Institute of Pathology; 1969. p. 60-64.
2. Kakizaki H, Zako M, Iwaki M, Mito H. Successful percutaneous incision and pathological examination of a rare nerve sheath myxoma: diagnosis and treatment. Jpn J Ophthalmol 2004;48:78-79.
crossref pmid
3. Papalas JA, Proia AD, Hitchcock M, et al. Neurothekeoma palpebrae: a report of 3 cases. Am J Dermatopathol 2010;32:374-379.
crossref pmid
4. Fetsch JF, Laskin WB, Miettinen M. Nerve sheath myxoma: a clinicopathologic and immunohistochemical analysis of 57 morphologically distinctive, S-100 protein- and GFAP-positive, myxoid peripheral nerve sheath tumors with a predilection for the extremities and a high local recurrence rate. Am J Surg Pathol 2005;29:1615-1624.
crossref pmid
5. Fetsch JF, Laskin WB, Hallman JR, et al. Neurothekeoma: an analysis of 178 tumors with detailed immunohistochemical data and long-term patient follow-up information. Am J Surg Pathol 2007;31:1103-1114.
crossref pmid
Fig. 1

(A) Photograph of the patient's eye at the time of his first visit. A mass (black arrow) at the medial canthus with drooped eyelid skin is observed. (B) Orbit computed tomography image shows an ill-defined enhancing soft tissue lesion (white arrow) at the medial canthal area of the right orbit. (C) Photograph of the patient's eye after complete excision of nerve sheath myxoma. The mass at the medial canthus and drooped eyelid skin had disappeared (black arrow). (D) Histopathologic analysis revealed epithelioid and stellate neoplastic Schwann cells (black arrow) with an abundant myxoid matrix (H&E, ×400). (E) Immunohistochemical staining for S-100 showed a strong positivity (S-100, ×200). Written informed consent from the patient was obtained.


Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next